Cargando…

Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review

INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social interactions, communication, and the presence of stereotyped, repetitive behaviors. Oxytocin (OXT) and arginine-vasopressin are neuropeptides produced in hypothalamus and they are relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilczyński, Krzysztof M, Zasada, Ida, Siwiec, Andrzej, Janas-Kozik, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750159/
https://www.ncbi.nlm.nih.gov/pubmed/31571878
http://dx.doi.org/10.2147/NDT.S207580
_version_ 1783452414204968960
author Wilczyński, Krzysztof M
Zasada, Ida
Siwiec, Andrzej
Janas-Kozik, Małgorzata
author_facet Wilczyński, Krzysztof M
Zasada, Ida
Siwiec, Andrzej
Janas-Kozik, Małgorzata
author_sort Wilczyński, Krzysztof M
collection PubMed
description INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social interactions, communication, and the presence of stereotyped, repetitive behaviors. Oxytocin (OXT) and arginine-vasopressin are neuropeptides produced in hypothalamus and they are related to processing emotions and social behavior. In the light of a growing number of scientific reports related to this issue, the two neurohormones started to be linked with the basis of neurodevelopmental disorders, including the ASD. The aim of this study was a systematic review of previous studies regarding the differences in OXT and vasopressin levels in ASD and neurotypical persons. MATERIALS AND METHODS: Literature review focused on publications in the last 10 years located via the MEDLINE/PubMed database as well as the Google Scholar browser. Selection was made by assumptive criteria of inclusion and exclusion. RESULTS: From the 487 studies qualified to the initial abstract analysis, 12 met the six inclusion criteria and were included in the full-text review. CONCLUSION: Currently, available study reports still do not provide unequivocal answers as to the differences in concentrations of those neuropeptides between children with ASD and neurotypical control. Therefore, it is necessary to continue the research taking into account necessity of proper homogenization of study groups, utilization of objective and quantifiable tools for ASD diagnosis and broadening the range of biochemical and molecular factors analyzed.
format Online
Article
Text
id pubmed-6750159
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67501592019-09-30 Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review Wilczyński, Krzysztof M Zasada, Ida Siwiec, Andrzej Janas-Kozik, Małgorzata Neuropsychiatr Dis Treat Review INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social interactions, communication, and the presence of stereotyped, repetitive behaviors. Oxytocin (OXT) and arginine-vasopressin are neuropeptides produced in hypothalamus and they are related to processing emotions and social behavior. In the light of a growing number of scientific reports related to this issue, the two neurohormones started to be linked with the basis of neurodevelopmental disorders, including the ASD. The aim of this study was a systematic review of previous studies regarding the differences in OXT and vasopressin levels in ASD and neurotypical persons. MATERIALS AND METHODS: Literature review focused on publications in the last 10 years located via the MEDLINE/PubMed database as well as the Google Scholar browser. Selection was made by assumptive criteria of inclusion and exclusion. RESULTS: From the 487 studies qualified to the initial abstract analysis, 12 met the six inclusion criteria and were included in the full-text review. CONCLUSION: Currently, available study reports still do not provide unequivocal answers as to the differences in concentrations of those neuropeptides between children with ASD and neurotypical control. Therefore, it is necessary to continue the research taking into account necessity of proper homogenization of study groups, utilization of objective and quantifiable tools for ASD diagnosis and broadening the range of biochemical and molecular factors analyzed. Dove 2019-09-10 /pmc/articles/PMC6750159/ /pubmed/31571878 http://dx.doi.org/10.2147/NDT.S207580 Text en © 2019 Wilczyński et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Wilczyński, Krzysztof M
Zasada, Ida
Siwiec, Andrzej
Janas-Kozik, Małgorzata
Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
title Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
title_full Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
title_fullStr Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
title_full_unstemmed Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
title_short Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
title_sort differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750159/
https://www.ncbi.nlm.nih.gov/pubmed/31571878
http://dx.doi.org/10.2147/NDT.S207580
work_keys_str_mv AT wilczynskikrzysztofm differencesinoxytocinandvasopressinlevelsinindividualssufferingfromtheautismspectrumdisordersvsgeneralpopulationasystematicreview
AT zasadaida differencesinoxytocinandvasopressinlevelsinindividualssufferingfromtheautismspectrumdisordersvsgeneralpopulationasystematicreview
AT siwiecandrzej differencesinoxytocinandvasopressinlevelsinindividualssufferingfromtheautismspectrumdisordersvsgeneralpopulationasystematicreview
AT janaskozikmałgorzata differencesinoxytocinandvasopressinlevelsinindividualssufferingfromtheautismspectrumdisordersvsgeneralpopulationasystematicreview